Timothy C. Tyson's most recent trade in Syros Pharmaceuticals Inc. was a trade of 6,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 5, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Syros Pharmaceuticals Inc. | Timothy C. Tyson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| Syros Pharmaceuticals Inc. | Timothy C. Tyson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 4,000 | 33,189 (0%) | 0% | 0 | Common Stock | |
| Syros Pharmaceuticals Inc. | Timothy C. Tyson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| Syros Pharmaceuticals Inc. | Timothy C. Tyson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 4,000 | 29,189 (0%) | 0% | 0 | Common Stock | |
| Syros Pharmaceuticals Inc. | Timothy C. Tyson | Director | Purchase of securities on an exchange or from another person at price $ 6.37 per share. | 29 Sep 2022 | 14,000 | 24,932 (0%) | 0% | 6.4 | 89,186 | Common Stock |
| Syros Pharmaceuticals Inc. | Timothy C. Tyson | Director | Purchase of securities on an exchange or from another person at price $ 5.72 per share. | 29 Sep 2022 | 2,932 | 10,932 (0%) | 0% | 5.7 | 16,770 | Common Stock |
| Syros Pharmaceuticals Inc. | Timothy C. Tyson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2022 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Syros Pharmaceuticals Inc. | Timothy C. Tyson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2022 | 8,000 | 8,000 (0%) | 0% | 0 | Common Stock | |
| Syros Pharmaceuticals Inc. | Timothy C. Tyson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2022 | 3,856 | 3,856 | - | - | Stock Option (right to buy) | |
| Syros Pharmaceuticals Inc. | Timothy C. Tyson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2022 | 3,856 | 3,856 | - | - | Stock Option (right to buy) | |
| Syros Pharmaceuticals Inc. | Timothy C. Tyson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2022 | 3,286 | 3,286 | - | - | Stock Option (right to buy) | |
| Syros Pharmaceuticals Inc. | Timothy C. Tyson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2022 | 2,848 | 2,848 | - | - | Stock Option (right to buy) | |
| Syros Pharmaceuticals Inc. | Timothy C. Tyson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2022 | 2,232 | 2,232 | - | - | Stock Option (right to buy) | |
| Syros Pharmaceuticals Inc. | Timothy C. Tyson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2022 | 2,191 | 2,191 | - | - | Stock Option (right to buy) | |
| Syros Pharmaceuticals Inc. | Timothy C. Tyson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2022 | 2,191 | 2,191 | - | - | Stock Option (right to buy) | |
| Syros Pharmaceuticals Inc. | Timothy C. Tyson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2022 | 1,094 | 1,094 | - | - | Stock Option (right to buy) | |
| Syros Pharmaceuticals Inc. | Timothy C. Tyson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2022 | 257 | 8,257 (0%) | 0% | - | Common Stock |